Deliver Your News to the World

Scientists at IBM and Genome Institute of Singapore Make New Stem Cell Discovery


Findings Show RNA Interference Has Much Larger Role in Cellular Functions and Processes Than Previously Thought

ARMONK, NY and SINGAPORE - A team of scientists at IBM (NYSE: IBM) and the Genome Institute of Singapore (GIS) have discovered that microRNAs --small molecules that are an important regulatory component in the machinery of living cells -- actually regulate the differentiation of stem cells and have roles that go way beyond what was previously thought.

The work uncovers new ways by which microRNAs regulate how genes are made and could provide alternative explanations for some observations that biologists have made in recent years.

The work is expected to provide new insights on cell process regulation and how it relates to the onset of diseases such as cancers, neurodegenerative disorders, diabetes and others. It is also expected to suggest future avenues for novel diagnostics and the development of therapeutics.

In 2003, IBM scientists developed a mathematical model for predicting microRNA targets. The model led to conjectures about an expanded role for microRNAs, which IBM set out to study with GIS scientists by focusing on mouse stem cells. IBM used computation to guide the experimental effort that was carried out at GIS.

“We have made yet another step towards understanding the intricate nature of microRNAs and the roles they play in the regulation of cellular processes,” said Isidore Rigoutsos, Manager of the Bioinformatics Group in IBM Research’s Computational Biology Center. “The finding that microRNAs can extensively target locations in the amino acid coding regions of a transcript is an exciting discovery and reveals another important aspect of microRNA activity.”

GIS Senior Group Leader, Dr. Bing Lim, added, “We learn from this study that the targeting of coding regions by microRNAs can also have a real impact on cells. We observed that a single microRNA forced into the powerful embryonic stem cell can impose differentiation. This is exciting because one could envisage using microRNAs as a small molecule to control the differentiation of stem cells, or to make new stem cells. The fun part of this research was the visualization of a trend of thought from computational prediction all the way to cell transformation.”

Details of Discovery

For more than a decade, microRNAs were assumed to primarily interact with their targets through the 3’ untranslated region (3’UTR) of the targets’ mRNA. The nucleotide sequences of the targeted locations were believed to be generally conserved across different organisms whereas interactions with mRNA regions beyond the 3’UTR were thought to be atypical.

Some of the new research findings suggest that microRNA targets in the amino acid coding region (CDS) of a gene’s mRNA may in fact be as frequent as those in the mRNA’s 3’UTR, providing experimental evidence to a conjecture put forth in an earlier publication by the two teams. It also shows that a gene’s CDS serves as template of microRNA targeting activity, in addition to its coding for the corresponding protein’s amino acid sequence.

Working with three microRNAs whose expression increases upon differentiation of mouse embryonic stem cells (ESCs), the teams show that Nanog, Oct4 and Sox2, three transcription factors that are central to maintaining the pluripotency of mouse ESCs and determining the initiation of differentiation, are controlled through their CDS region by the three studied microRNAs. By introducing mutations at the identified target locations, the two teams showed that they could prevent the downregulation of these transcription factors and delay stem cell differentiation.

For the majority of the validated microRNA targets, their sequence is not conserved in the rhesus and mouse counterparts of Nanog, Oct4 and Sox2. This suggests that seeking putative microRNA targets by aligning the instances of a gene across different organisms will underestimate the number of bona fide microRNA targets. Additionally, the studied microRNAs generally have multiple targets in the CDS region of the same gene possibly suggesting an underlying need for redundancy that can ensure the downregulation of the intended target. Finally, several of the studied targets stride exon-exon junctions: this finding suggests a role for microRNAs that of the selective targeting of a gene’s splice variants.

“This discovery has vast implications for the role that computational models can play in biological science,” said Ajay Royyuru, Senior Manager for the Computational Biology Center at IBM Research. “Computational biology allows scientists to develop theories using powerful computers and even preliminarily prove those theories prior to conducting experiments in wet labs -- which reduces the time spent on trial and error throughout the process of scientific discovery.”

Prof Edison Liu, Executive Director of GIS, said, “This work is a great example of how future medical discovery will progressively require the joint efforts of computer scientists working in conjunction with biologists. The complexity of the control of human cells through regulatory networks demands computational modeling in order to decipher the signals from the noise. But in the end, it still boils down to doing the lab experiment.”

The report on this work, “MiRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation,” by I. Rigoutsos of IBM T.J. Watson Research Center, Yorktown Heights, NY, and, Y. Tay, J. Zhang, A. Thomson, and B. Lim of the Genome Institute of Singapore, is currently available online at and will be published in an upcoming issue of Nature.

About IBM Research
IBM Research is a prolific and far-reaching commercial lab, with five Nobel Prize winners and 15 years of US patent leadership. IBM Research is engaged with many public and private research organizations around the world to better understand and address some of the biggest issues of our time. For more information, visit

About the Genome Institute of Singapore
The Genome Institute of Singapore (GIS) is a member of the Agency for Science, Technology and Research (A*STAR). It is a national initiative with a global vision that seeks to use genomic sciences to improve public health and public prosperity. Established in 2001 as a centre for genomic discovery, the GIS will pursue the integration of technology, genetics and biology towards the goal of individualized medicine. The key research areas at the GIS include Systems Biology, Stem Cell & Developmental Biology, Cancer Biology & Pharmacology, Human Genetics, Infectious Diseases, Genomic Technologies, and Computational & Mathematical Biology. The genomics infrastructure at the GIS is utilized to train new scientific talent, to function as a bridge for academic and industrial research, and to explore scientific questions of high impact. For more information, please visit


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.